{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:11:07Z","timestamp":1773850267148,"version":"3.50.1"},"reference-count":10,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,1,31]]},"DOI":"10.1536\/ihj.19-419","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T22:05:11Z","timestamp":1579212311000},"page":"191-194","source":"Crossref","is-referenced-by-count":5,"title":["Chemotherapy Improved Pulmonary Arterial Hypertension in a Patient with Chronic-Active Epstein-Barr Virus Infection"],"prefix":"10.1536","volume":"61","author":[{"given":"Satoshi","family":"Akagi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Miki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Sando","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Okayama University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuharu","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Okayama University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Sarashina","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Luo L, Wang H, Fan H, Xie J, Qiu Z, Li T. The clinical characteristics and the features of immunophenotype of peripheral lymphocytes of adult onset chronic active Epstein-Barr virus disease at a Tertiary Care Hospital in Beijing. Medicine (Baltimore) 2018; 97: e9854.","DOI":"10.1097\/MD.0000000000009854"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Fukuda Y, Momoi N, Akaihata M, <i>et al<\/i>. Pulmonary arterial hypertension associated with chronic active Epstein-Barr virus infection. Pediatr Int 2015; 57: 731-4.","DOI":"10.1111\/ped.12578"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hashimoto T, Sakata Y, Fukushima K, <i>et al<\/i>. Pulmonary arterial hypertension associated with chronic active Epstein-Barr virus infection. Intern Med 2011; 50: 119-24.","DOI":"10.2169\/internalmedicine.50.4143"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Arai A. Advances in the study of chronic active epstein-barr virus infection: Clinical features under the 2016 WHO Classification and Mechanisms of Development. Front Pediatr 2019; 7: 14.","DOI":"10.3389\/fped.2019.00014"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Galie N, Humbert M, Vachiery JL, <i>et al<\/i>. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37: 67-119.","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Galie N, Barbera JA, Frost AE, <i>et al<\/i>. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med 2015; 373: 834-44.","DOI":"10.1056\/NEJMoa1413687"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Okano M, Kawa K, Kimura H, <i>et al<\/i>. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005; 80: 64-9.","DOI":"10.1002\/ajh.20398"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Cracowski JL, Chabot F, Labarere J, <i>et al<\/i>. Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension. Eur Respir J 2014; 43: 915-7.","DOI":"10.1183\/09031936.00151313"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tamura Y, Phan C, Tu L, <i>et al<\/i>. Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension. J Clin Invest 2018; 128: 1956-70.","DOI":"10.1172\/JCI96462"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hernandez-Sanchez J, Harlow L, Church C, <i>et al<\/i>. Clinical trial protocol for TRANSFORM-UK: A therapeutic open-label study of tocilizumab in the treatment of pulmonary arterial hypertension. Pulm Circ 2018; 8: 2045893217735820.","DOI":"10.1177\/2045893217735820"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/1\/61_19-419\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T03:47:24Z","timestamp":1580528844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/1\/61_19-419\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.19-419","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]}}}